Guided Therapeutics (GTHP) EPS (Basic) (2010 - 2026)
Guided Therapeutics' (GTHP) quarterly EPS (Basic) came in at -$0.01 in Q2 2026, up 99.96% year-over-year from -$0.0 in Q2 2025, and up 99.97% quarter-over-quarter from -$18.5 in Q1 2026.
Analysis
Guided Therapeutics (GTHP) EPS (Basic) (2010 - 2026) Analysis & Trends
Guided Therapeutics has disclosed EPS (Basic) across 17 years of filings, most recently posting -$0.01 for Q2 2026.
- In Q2 2026, EPS (Basic) rose 99.96% year-over-year to -$0.01; the TTM figure through Jun 2026 stood at -$0.04 (up 99.92% YoY), while the FY2025 annual figure was -$61.11, down 29.14% from the prior year.
- EPS (Basic) came in at -$0.01 for Q2 2026 at Guided Therapeutics, up from -$18.5 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.01 in Q2 2026 to a low of -$32.54 in Q2 2023.
- Average EPS (Basic) over 5 years is -$11.3, with a median of -$12.71 recorded in 2024.
- Year-over-year, EPS (Basic) tumbled 84998.27% in 2023 and surged 99.96% in 2026.
- Over 5 years, EPS (Basic) stood at -$0.06 in 2022, then sank by 16552.93% to -$9.51 in 2023, then plunged by 34.39% to -$12.79 in 2024, then tumbled by 77.43% to -$22.68 in 2025, then soared by 99.97% to -$0.01 in 2026.
- Per Business Quant data, the three most recent EPS (Basic) figures were -$0.01 in Q2 2026, -$18.5 in Q1 2026, and -$22.68 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 0.53 |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 2.32 |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 1.16 |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 3.33 |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 0.62 |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 0.42 |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 0.65 |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 2.06 |
| 10 | Guided Therapeutics | 24.13 Mn | 24.12 Mn | - | -0.01 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.01 |
| Mar 31, 2026 | -18.50 |
| Dec 31, 2025 | -22.68 |
| Sep 30, 2025 | -14.34 |
| Jun 30, 2025 | -15.63 |
| Mar 31, 2025 | -8.46 |
| Dec 31, 2024 | -12.79 |
| Sep 30, 2024 | -12.64 |
| Jun 30, 2024 | -13.84 |
| Mar 31, 2024 | -8.05 |
| Dec 31, 2023 | -9.51 |
| Sep 30, 2023 | -14.54 |
| Jun 30, 2023 | -32.54 |
| Mar 31, 2023 | -19.66 |
| Dec 31, 2022 | -0.06 |
| Sep 30, 2022 | -0.03 |
| Jun 30, 2022 | -0.04 |
| Mar 31, 2022 | -0.05 |
| Dec 31, 2021 | -0.04 |
| Sep 30, 2021 | 0.00 |